Table 2.
Evaluable patients (n = 31) | |
---|---|
Objective response rate (95% CI) | 32.3(14.8 − 49.7) |
Complete response (n, %) | 0 |
Partial response (n, %) | 10(32.3) |
Stable disease (n, %) | 17(54.8) |
Progressive disease (n, %) | 4(12.9) |
DCR (n, %), 95% CI | 87.1(74.6 − 99.6) |
Median overall survival, months (95% CI) | 11.7(8.3 − 12.9) |
Median progression-free survival, months (95% CI) | 7.9(7.1 − 8.7) |
DCR, disease control rate; RECIST, response evaluation criteria in solid tumors